MedTrace Logo

To Evaluate Compliance to Treatment Regimen (Rate of Deviations From the Prescribed Regimen) in Polish Females Treated With Different Low Dose Oral Contraceptives

NCT01198444 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11884

Last updated 2011-11-02

No results posted yet for this study

Summary

Adherence to the dosing scheme is the principal element of Combined Oral Contraceptives efficiency. On the other hand noncompliance seemed to be an inseparable element of any oral treatment. The aim of the study is to evaluate in everyday practice the relation between dosage errors and indicated factors, potentially influencing the compliance with the dosing scheme.

Conditions

  • Contraception

Interventions

DRUG

EE/DRSP (Yasmin Product Family)

One tablet per day, orally, 21 tablets followed by 7 days, during three consecutive cycles.

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2008-05-31
Completion
2008-05-31

Countries

  • Poland

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01198444 on ClinicalTrials.gov